They also noted that both gluten and soy protein similarly increased GLP-1 secretion
Whether this mechanism occurs in other species remains to be investigated
Key observations from studies on intranasal antifungal therapy include: Significant clinical improvement: Many patients treated with intranasal antifungal medication have reported clinical improvement, with reductions in various symptoms, including fatigue, headache, cognitive dysfunction, and sinus-specific symptoms
This also provides a mechanism for exploring the application of other antioxidant drugs in ovarian diseases
IGF-1 also reduces inflammation in the damaged areas, enhancing the activity of cells involved in tissue renewal (Yakar et al., 2019)
All the RCT included in the study were published between 1980 and 2024